PARIS--(BUSINESS WIRE)--Jan. 5, 2006--BioAlliance Pharma (EURONEXT:BIO)(BOURSE:BIO), an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections, announced today that Francois Sarkozy, MD, DEA, MBA, has been elected to serve as Vice-Chairman and independent member of its Supervisory Board (Conseil de Surveillance). Dr. Sarkozy is currently a Managing Partner of AEC Partners, a Paris-based healthcare consultancy.
